Across TCGA pan-cancer cohorts, GAPDHP42 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of GAPDHP42’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where GAPDHP42 RNA is repressed in tumor relative to normal tissue. In most cancer types GAPDHP42 is over-expressed in tumor, although a few such as LUAD and KICH show the opposite, repressed pattern.

LUAD, KICH, and BRCA are the cancer types where GAPDHP42 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAPDHP42 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	III,IV	−0.167	.001	4	view →
KICH	Male	III,IV	−0.095	.016	4	view →
BRCA	All	III,IV	−0.196	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: GAPDHP42 RNA expression & survival · all GAPDHP42 data types